TD Cowen Downgrades Boston Scientific to Hold, Lowers Price Target to $46
Benzinga Newsdesk 23 hours ago
Analyst RatingsNewsDowngradesPrice TargetHot
TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.
TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.